Natural History of Genital Warts : Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) VaccineGARLAND, Suzanne M; STEBEN, Marc; SINGS, Heather L et al.The Journal of infectious diseases. 2009, Vol 199, Num 6, pp 805-814, issn 0022-1899, 10 p.Article

Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccineBROWN, Darron R; FIFE, Kenneth H; SMITH, Judith F et al.Vaccine. 2004, Vol 22, Num 21-22, pp 2936-2942, issn 0264-410X, 7 p.Article

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseasesGARLAND, Suzanne M; HERNANDEZ-AVILA, Mauricio; TADDEO, Frank J et al.The New England journal of medicine. 2007, Vol 356, Num 19, pp 1928-1943, issn 0028-4793, 16 p.Article

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18VILLA, Luisa L; AULT, Kevin A; KURMAN, Robert J et al.Vaccine. 2006, Vol 24, Num 27-28, pp 5571-5583, issn 0264-410X, 13 p.Article

Immunogenicity and reactogenicity of a novel vaccine for human papillomavirus 16 : A 2-year randomized controlled clinical trialPOLAND, Gregory A; JACOBSON, Robert M; KOUTSKY, Laura A et al.Mayo Clinic proceedings. 2005, Vol 80, Num 5, pp 601-610, issn 0025-6196, 10 p.Article

Impact of a prophylactic quadrivalent human papillomavirus (types 6,11,16,18) L1 virus-like particle vaccine in a sexually active population of North American womenBARR, Eliav; GAUSE, Christine K; BAUTISTA, Oliver M et al.American journal of obstetrics and gynecology. 2008, Vol 198, Num 3, pp 261-263, issn 0002-9378, 3 p.Article